PERCEPTIVE ADVISORS LLC

Insider Reports History

Location
New York, NY
Signature
/s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PERCEPTIVE ADVISORS LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Crinetics Pharmaceuticals, Inc. 10%+ Owner Common Stock 5,321,032 $200,336,855 $37.65 18 Apr 2022 Indirect
VBI Vaccines Inc/BC 10%+ Owner Common Stock 41,440,729 $137,168,813 $3.31 06 Apr 2023 Indirect
SOLENO THERAPEUTICS INC 10%+ Owner Common Stock 3,074,542 $112,175,587 $36.49 28 Sep 2023 Indirect
ALBIREO PHARMA, INC. 10%+ Owner Common Stock 1,939,723 $84,959,867 $43.80 13 Oct 2022 Indirect
MeiraGTx Holdings plc Director, 10%+ Owner Ordinary Shares 10,231,103 $80,928,024 $7.91 31 Dec 2025 Indirect
ADMA BIOLOGICS, INC. 10%+ Owner Common Stock 13,262,375 $59,945,935 $4.52 30 Sep 2021 Indirect
Astria Therapeutics, Inc. Director Common Stock 4,873,721 $58,923,287 $12.09 01 Feb 2024 Indirect
Verrica Pharmaceuticals Inc. 10%+ Owner Common Stock 7,099,182 $51,398,078 $7.24 29 Dec 2023 Indirect
Solid Biosciences Inc. Director, 10%+ Owner Common Stock 11,833,539 $47,689,162 $4.03 19 Feb 2025 Indirect
Aldeyra Therapeutics, Inc. 10%+ Owner Common Stock 5,875,851 $27,829,793 $4.74 03 Apr 2025 Indirect
AGILE THERAPEUTICS INC 10%+ Owner Common Stock 21,654,485 $18,406,312 $0.8500 13 Oct 2021 Indirect
Orchestra BioMed Holdings, Inc. 10%+ Owner Common Stock 5,292,556 $14,554,529 $2.75 01 Aug 2025 Indirect
VYNE Therapeutics Inc. 10%+ Owner Common Stock 4,935,057 $11,251,930 $2.28 16 Aug 2021 Indirect
Athira Pharma, Inc. Director, 10%+ Owner Series A Warrant (right to buy) 1,279,526 $8,124,990 $6.35 23 Dec 2025 Indirect
Athira Pharma, Inc. Director, 10%+ Owner Series B Warrant (right to buy) 1,181,101 $7,499,991 $6.35 23 Dec 2025 Indirect
Astria Therapeutics, Inc. Director Pre-funded Warrants (right to buy) 921,093 $5,999,079 $6.51 16 Oct 2023 Indirect
CARGO Therapeutics, Inc. Former 10% Owner Common Stock 333,333 $4,999,995 $15.00 14 Nov 2023 Indirect
Acrivon Therapeutics, Inc. 10%+ Owner Common Stock 3,104,139 $4,159,546 $1.34 01 May 2025 Indirect
Orchestra BioMed Holdings, Inc. 10%+ Owner Pre-funded Warrants (right to buy) 1,500,000 $4,124,849 $2.75 01 Aug 2025 Indirect
Adagio Medical Holdings, Inc. Director, 10%+ Owner Pre-Funded Warrant (right to buy) 2,190,496 $3,505,231 $1.60 20 Oct 2025 Indirect
Rain Therapeutics Inc. 10%+ Owner Common Stock 2,487,019 $3,009,293 $1.21 12 Oct 2021 Indirect
IsoPlexis Corp 10%+ Owner Common Stock 3,554,587 $2,581,697 $0.7263 12 Oct 2021 By Perceptive Life Sciences Master Fund, Ltd.
Astria Therapeutics, Inc. Director Common Warrants (right to buy) 345,409 $2,249,994 $6.51 16 Oct 2023 Indirect
Athira Pharma, Inc. Director, 10%+ Owner Common Stock 329,756 $2,093,950 $6.35 23 Dec 2025 Indirect
CHEMBIO DIAGNOSTICS, INC. 10%+ Owner Common Stock 3,672,662 $1,652,698 $0.4500 04 Apr 2023 Indirect
Quotient Ltd 10%+ Owner Ordinary Shares, nil par value 7,945,211 $635,617 $0.0800 31 Oct 2022 Indirect
IsoPlexis Corp 10%+ Owner Common Stock 335,962 $244,009 $0.7263 12 Oct 2021 By Perceptive Credit Holdings III, LP
IsoPlexis Corp 10%+ Owner Common Stock 204,949 $148,854 $0.7263 12 Oct 2021 By PCOF EQ AIV III, LP
LianBio Director, 10%+ Owner Ordinary Shares 17,082 $81,310 $4.76 15 Feb 2024 Indirect
Lyra Therapeutics, Inc. 10%+ Owner Common Stock 14,026 $54,702 $3.90 13 Nov 2025 Indirect
Cerevel Therapeutics Holdings, Inc. Director Common Stock 0 $0 $41.54 20 Feb 2024 Indirect
Adagio Medical Holdings, Inc. Director, 10%+ Owner Common Stock 9,675,684 22 Jan 2025 Direct
Athira Pharma, Inc. Director, 10%+ Owner Pre-Funded Warrant (right to buy) 5,502,402 23 Dec 2025 Indirect
LianBio Director, 10%+ Owner American Depository Shares 3,728,491 15 Feb 2024 Indirect
Landos Biopharma, Inc. 10%+ Owner Pre-funded Warrant 3,636,363 10 Jan 2023 Indirect
LEAP THERAPEUTICS, INC. 10%+ Owner Warrants (right to buy) 3,508,771 24 Sep 2021 Indirect
AGILE THERAPEUTICS INC 10%+ Owner Warrants (right to buy) 2,687,280 13 Oct 2021 Indirect
Adagio Medical Holdings, Inc. Director, 10%+ Owner Tranche A Warrant ("Common Warrant" right to buy) 1,344,999 20 Oct 2025 Indirect
Adagio Medical Holdings, Inc. Director, 10%+ Owner Tranche B Warrant ("Common Warrant" right to buy) 1,344,999 20 Oct 2025 Indirect
Adagio Medical Holdings, Inc. Director, 10%+ Owner Tranche C Warrant ("Common Warrant" right to buy) 1,344,999 20 Oct 2025 Indirect
SOLENO THERAPEUTICS INC 10%+ Owner Pre-funded warrants (right to buy) 250,000 28 Sep 2023 Indirect
Adagio Medical Holdings, Inc. Director, 10%+ Owner Common Stock 200,902 22 Jan 2025 Indirect
Solid Biosciences Inc. Director, 10%+ Owner Director Stock Option (Right to Buy) 77,500 12 Jun 2025 Indirect
MeiraGTx Holdings plc Director, 10%+ Owner Restricted Share Units 45,000 12 Jun 2025 Indirect
Nautilus Biotechnology, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 45,000 14 Jun 2024 Indirect
CARGO Therapeutics, Inc. Former 10% Owner Series A-1 Convertible Preferred Stock 0 14 Nov 2023 Indirect
IsoPlexis Corp 10%+ Owner Series D Redeemable Convertible Preferred Stock 0 12 Oct 2021 By PCOF EQ AIV III, LP
IsoPlexis Corp 10%+ Owner Series D Redeemable Convertible Preferred Stock 0 12 Oct 2021 By Perceptive Credit Holdings III, LP
IsoPlexis Corp 10%+ Owner Series D Redeemable Convertible Preferred Stock 0 12 Oct 2021 By Perceptive Life Sciences Master Fund, Ltd.
LianBio Director, 10%+ Owner Stock Option (Right to Buy) 0 15 Feb 2024 Indirect

Insider Reports Filed by PERCEPTIVE ADVISORS LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MGTX MeiraGTx Holdings plc 31 Dec 2025 1 -$18,193,000 4 Director, 10%+ Owner 02 Jan 2026, 16:15
ATHA Athira Pharma, Inc. 23 Dec 2025 9 +$82,498,150 4 Director, 10%+ Owner 23 Dec 2025, 17:12
LYRA Lyra Therapeutics, Inc. 11 Nov 2025 6 -$182,515 4 10%+ Owner 13 Nov 2025, 17:07
LYRA Lyra Therapeutics, Inc. 06 Nov 2025 6 -$344,219 4 10%+ Owner 10 Nov 2025, 17:08
ADGM Adagio Medical Holdings, Inc. 20 Oct 2025 4 +$4,250,092 4 Director, 10%+ Owner 22 Oct 2025, 16:33
OBIO Orchestra BioMed Holdings, Inc. 01 Aug 2025 2 +$6,049,850 4 10%+ Owner 05 Aug 2025, 10:46
MGTX MeiraGTx Holdings plc 12 Jun 2025 1 $0 4 Director, 10%+ Owner 16 Jun 2025, 16:31
SLDB Solid Biosciences Inc. 12 Jun 2025 1 $0 4 Director, 10%+ Owner 13 Jun 2025, 17:05
ACRV Acrivon Therapeutics, Inc. 30 Apr 2025 2 -$1,017,919 4 10%+ Owner 01 May 2025, 19:07
ACRV Acrivon Therapeutics, Inc. 25 Apr 2025 3 -$2,744,946 4 10%+ Owner 29 Apr 2025, 19:26
ALDX Aldeyra Therapeutics, Inc. 03 Apr 2025 1 -$4,828,000 4 10%+ Owner 07 Apr 2025, 18:43
SLDB Solid Biosciences Inc. 19 Feb 2025 1 +$20,150,000 4 Director, 10%+ Owner 21 Feb 2025, 16:17
ADGM Adagio Medical Holdings, Inc. 22 Jan 2025 1 $0 4 Director, 10%+ Owner 14 Feb 2025, 16:35
MGTX MeiraGTx Holdings plc 12 Aug 2024 1 +$5,000,000 4 Director, 10%+ Owner 14 Aug 2024, 18:54
ADGM Aja Holdco, Inc. 31 Jul 2024 0 $0 3 Director, 10%+ Owner 01 Aug 2024, 17:18
OBIO Orchestra BioMed Holdings, Inc. 11 Jul 2024 0 $0 3 10%+ Owner 17 Jul 2024, 16:38
/report/000106299324013107-perceptive-advisors-llc-2024-06-17 VAPOTHERM INC 17 Jun 2024 0 $0 3 10%+ Owner 27 Jun 2024, 19:45
NAUT Nautilus Biotechnology, Inc. 14 Jun 2024 1 $0 4 Director, 10%+ Owner 17 Jun 2024, 18:02
SLDB Solid Biosciences Inc. 11 Jun 2024 1 $0 4 Director, 10%+ Owner 19 Nov 2024, 16:20
MGTX MeiraGTx Holdings plc 06 Jun 2024 1 $0 4 Director, 10%+ Owner 07 Jun 2024, 18:48
ACRV Acrivon Therapeutics, Inc. 11 Apr 2024 1 +$20,000,500 4 10%+ Owner 15 Apr 2024, 08:53
ALDX Aldeyra Therapeutics, Inc. 04 Apr 2024 2 +$833,867 4 10%+ Owner 08 Apr 2024, 17:32
ALDX Aldeyra Therapeutics, Inc. 01 Apr 2024 3 +$1,934,505 4 10%+ Owner 03 Apr 2024, 17:22
/report/000106299324003957-perceptive-advisors-llc-2024-02-20 Cerevel Therapeutics Holdings, Inc. 20 Feb 2024 1 $0 4 Director 21 Feb 2024, 16:54
LIANY LianBio 15 Feb 2024 6 -$3.36 4 Director, 10%+ Owner 20 Feb 2024, 17:25
ATXS Astria Therapeutics, Inc. 01 Feb 2024 1 +$29,999,522 4 Director 05 Feb 2024, 17:02
SLDB Solid Biosciences Inc. 11 Jan 2024 1 +$18,861,243 4 Director, 10%+ Owner 12 Jan 2024, 17:15
VRCA Verrica Pharmaceuticals Inc. 27 Dec 2023 3 +$2,305,132 4 10%+ Owner 29 Dec 2023, 17:27
ATHA Athira Pharma, Inc. 27 Dec 2023 3 +$1,462,895 4 Director, 10%+ Owner 29 Dec 2023, 17:24
VRCA Verrica Pharmaceuticals Inc. 21 Dec 2023 3 +$3,256,191 4 10%+ Owner 26 Dec 2023, 19:21
ATXS Astria Therapeutics, Inc. 21 Dec 2023 1 +$4,588,000 4 Director 22 Dec 2023, 14:51
VRCA Verrica Pharmaceuticals Inc. 15 Dec 2023 3 +$6,941,716 4 10%+ Owner 19 Dec 2023, 17:52
CRGX CARGO Therapeutics, Inc. 14 Nov 2023 4 +$9,999,990 4 Former 10% Owner 14 Nov 2023, 16:32
CRGX CARGO Therapeutics, Inc. 09 Nov 2023 0 $0 3 10%+ Owner 09 Nov 2023, 18:37
ALDX Aldeyra Therapeutics, Inc. 16 Oct 2023 2 -$4,453,308 4 10%+ Owner 18 Oct 2023, 17:15
ATXS Astria Therapeutics, Inc. 16 Oct 2023 6 +$25,998,150 4 Director 18 Oct 2023, 16:11
/report/000106299323019470-perceptive-advisors-llc-2023-10-16 Cerevel Therapeutics Holdings, Inc. 16 Oct 2023 1 +$19,999,990 4 Director 17 Oct 2023, 16:53
SLNO SOLENO THERAPEUTICS INC 26 Sep 2023 16 +$20,111,416 4 10%+ Owner 28 Sep 2023, 15:45
LIANY LianBio 21 Jun 2023 2 $0 4 Director, 10%+ Owner 23 Jun 2023, 16:09
NAUT Nautilus Biotechnology, Inc. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 21:07
MGTX MeiraGTx Holdings plc 08 Jun 2023 2 $0 4 Director, 10%+ Owner 12 Jun 2023, 16:07
SLDB Solid Biosciences Inc. 06 Jun 2023 1 $0 4 Director, 10%+ Owner 08 Jun 2023, 16:11
SLNO SOLENO THERAPEUTICS INC 02 Jun 2023 3 +$853,681 4 10%+ Owner 06 Jun 2023, 16:16
LYRA Lyra Therapeutics, Inc. 31 May 2023 2 +$8,999,999 4 Director, 10%+ Owner 02 Jun 2023, 16:11
SLNO SOLENO THERAPEUTICS INC 30 May 2023 3 +$188,175 4 10%+ Owner 01 Jun 2023, 17:41
SLNO SOLENO THERAPEUTICS INC 24 May 2023 3 +$449,825 4 10%+ Owner 26 May 2023, 17:57
SLNO SOLENO THERAPEUTICS INC 19 May 2023 3 +$406,075 4 10%+ Owner 23 May 2023, 18:47
SLNO SOLENO THERAPEUTICS INC 11 May 2023 0 $0 3 10%+ Owner 18 May 2023, 16:31
MGTX MeiraGTx Holdings plc 05 May 2023 1 +$25,000,000 4 Director, 10%+ Owner 15 May 2023, 20:12
/report/000089924323010945-perceptive-advisors-llc-2023-04-04 CHEMBIO DIAGNOSTICS, INC. 04 Apr 2023 0 $0 3 10%+ Owner 06 Apr 2023, 21:30
/report/000089924323010886-perceptive-advisors-llc-2023-04-04 VBI Vaccines Inc/BC 04 Apr 2023 3 -$1,475,605 4 10%+ Owner 06 Apr 2023, 17:51
/report/000106299323000853-perceptive-advisors-llc-2023-01-10 Landos Biopharma, Inc. 10 Jan 2023 2 +$16,690,909 4 10%+ Owner 11 Jan 2023, 17:45
ATXS Astria Therapeutics, Inc. 19 Dec 2022 1 +$9,999,998 4 Director 21 Dec 2022, 15:52
SLDB Solid Biosciences Inc. 13 Dec 2022 1 $0 4 Director, 10%+ Owner 15 Dec 2022, 16:34
SLDB Solid Biosciences Inc. 02 Dec 2022 3 +$15,249,996 4 Director, 10%+ Owner 06 Dec 2022, 15:41
ACRV Acrivon Therapeutics, Inc. 17 Nov 2022 0 $0 3 10%+ Owner 18 Nov 2022, 15:34
/report/000106299322021420-perceptive-advisors-llc-2022-10-31 Quotient Ltd 31 Oct 2022 1 -$660,449 4 10%+ Owner 02 Nov 2022, 16:58
/report/000106299322020786-perceptive-advisors-llc-2022-10-11 ALBIREO PHARMA, INC. 11 Oct 2022 7 -$9,505,547 4 10%+ Owner 13 Oct 2022, 19:37
LIANY LianBio 18 Aug 2022 1 +$2,395,776 4 Director, 10%+ Owner 22 Aug 2022, 09:17
/report/000106299322018390-perceptive-advisors-llc-2022-08-16 Cerevel Therapeutics Holdings, Inc. 16 Aug 2022 2 +$149,875,000 4 Director 18 Aug 2022, 17:10
ALDX Aldeyra Therapeutics, Inc. 09 Aug 2022 2 +$867,750 4 10%+ Owner 11 Aug 2022, 16:08
ALDX Aldeyra Therapeutics, Inc. 08 Aug 2022 1 +$702,280 4 10%+ Owner 10 Aug 2022, 16:10
ALDX Aldeyra Therapeutics, Inc. 05 Aug 2022 1 +$979,950 4 10%+ Owner 09 Aug 2022, 16:08
ALDX Aldeyra Therapeutics, Inc. 04 Aug 2022 1 +$586,767 4 10%+ Owner 08 Aug 2022, 16:09
ALDX Aldeyra Therapeutics, Inc. 03 Aug 2022 1 +$584,000 4 10%+ Owner 05 Aug 2022, 16:10
ALDX Aldeyra Therapeutics, Inc. 02 Aug 2022 1 +$2,305,350 4 10%+ Owner 04 Aug 2022, 16:10
ALDX Aldeyra Therapeutics, Inc. 01 Aug 2022 1 +$728,134 4 10%+ Owner 03 Aug 2022, 17:16
ALDX Aldeyra Therapeutics, Inc. 29 Jul 2022 1 +$1,117,279 4 10%+ Owner 02 Aug 2022, 16:27
ALDX Aldeyra Therapeutics, Inc. 28 Jul 2022 1 +$596,960 4 10%+ Owner 01 Aug 2022, 17:37
VRCA Verrica Pharmaceuticals Inc. 05 Jul 2022 1 +$2,999,999 4 10%+ Owner 05 Jul 2022, 17:32
ATHA Athira Pharma, Inc. 29 Jun 2022 2 +$4,100,372 4 Director, 10%+ Owner 01 Jul 2022, 14:24
LIANY LianBio 23 Jun 2022 2 $0 4 Director, 10%+ Owner 27 Jun 2022, 17:38
NAUT Nautilus Biotechnology, Inc. 15 Jun 2022 1 $0 4 Director, 10%+ Owner 17 Jun 2022, 17:43
MGTX MeiraGTx Holdings plc 07 Jun 2022 2 $0 4 Director, 10%+ Owner 13 Jun 2022, 18:11
SLDB Solid Biosciences Inc. 07 Jun 2022 1 $0 4 Director, 10%+ Owner 09 Jun 2022, 18:20
LIANY LianBio 26 May 2022 1 +$215,970 4 Director, 10%+ Owner 27 May 2022, 10:06
LIANY LianBio 23 May 2022 3 +$442,364 4 Director, 10%+ Owner 25 May 2022, 18:51
ATHA Athira Pharma, Inc. 20 May 2022 1 $0 4 Director, 10%+ Owner 27 May 2022, 17:19
CRNX Crinetics Pharmaceuticals, Inc. 18 Apr 2022 1 +$3,499,983 4 10%+ Owner 18 Apr 2022, 17:39
LYRA Lyra Therapeutics, Inc. 12 Apr 2022 1 +$24,999,997 4 Director, 10%+ Owner 14 Apr 2022, 16:53
NAUT Nautilus Biotechnology, Inc. 08 Dec 2021 1 +$1,072,000 4 Director 10 Dec 2021, 15:05
/report/000106299321012195-perceptive-advisors-llc-2021-12-01 VBI Vaccines Inc/BC 01 Dec 2021 1 -$8,961,703 4 10%+ Owner 03 Dec 2021, 17:22
LIANY LianBio 03 Nov 2021 2 +$36,270,200 4 Director, 10%+ Owner 05 Nov 2021, 13:47
LIANY LianBio 01 Nov 2021 12 +$3,210,000 4 Director, 10%+ Owner 03 Nov 2021, 18:59
LIANY LianBio 29 Oct 2021 0 $0 3 Director, 10%+ Owner 29 Oct 2021, 18:46
CRNX Crinetics Pharmaceuticals, Inc. 25 Oct 2021 1 +$23,760,000 4 10%+ Owner 25 Oct 2021, 14:47
/report/000106299321009586-perceptive-advisors-llc-2021-10-13 AGILE THERAPEUTICS INC 13 Oct 2021 2 +$4,874,376 4 10%+ Owner 15 Oct 2021, 16:05
/report/000106299321009543-perceptive-advisors-llc-2021-10-12 IsoPlexis Corp 12 Oct 2021 7 +$12,750,000 4 10%+ Owner 14 Oct 2021, 17:07
/report/000106299321009486-perceptive-advisors-llc-2021-10-07 Rain Therapeutics Inc. 07 Oct 2021 7 -$667,479 4 10%+ Owner 13 Oct 2021, 17:47
/report/000106299321009329-perceptive-advisors-llc-2021-10-07 IsoPlexis Corp 07 Oct 2021 0 $0 3 10%+ Owner 07 Oct 2021, 17:27
ADMA ADMA BIOLOGICS, INC. 28 Sep 2021 3 -$299,236 4 10%+ Owner 30 Sep 2021, 19:27
ADMA ADMA BIOLOGICS, INC. 24 Sep 2021 2 -$622,500 4 10%+ Owner 29 Sep 2021, 19:18
LPTX LEAP THERAPEUTICS, INC. 24 Sep 2021 1 +$9,996,489 4 10%+ Owner 28 Sep 2021, 16:21
ADMA ADMA BIOLOGICS, INC. 23 Sep 2021 1 -$990,600 4 10%+ Owner 28 Sep 2021, 16:18
/report/000089924321034678-perceptive-advisors-llc-2021-08-27 Landos Biopharma, Inc. 27 Aug 2021 1 $0 4 Director, 10%+ Owner 31 Aug 2021, 21:31
/report/000089924321034577-perceptive-advisors-llc-2021-08-26 Cerevel Therapeutics Holdings, Inc. 26 Aug 2021 1 +$2,057,061 4 Director 31 Aug 2021, 14:15
/report/000106299321007963-perceptive-advisors-llc-2021-08-23 Cerevel Therapeutics Holdings, Inc. 23 Aug 2021 3 +$4,833,885 4 Director 25 Aug 2021, 19:14
ADMA ADMA BIOLOGICS, INC. 17 Aug 2021 3 -$2,333,781 4 10%+ Owner 19 Aug 2021, 19:58
VYNE VYNE Therapeutics Inc. 16 Aug 2021 1 -$435,000 4 10%+ Owner 18 Aug 2021, 19:19
VYNE VYNE Therapeutics Inc. 13 Aug 2021 1 -$460,000 4 10%+ Owner 17 Aug 2021, 16:46
VYNE VYNE Therapeutics Inc. 12 Aug 2021 1 -$755,740 4 10%+ Owner 16 Aug 2021, 18:24
/report/000106299321006425-perceptive-advisors-llc-2021-07-07 Cerevel Therapeutics Holdings, Inc. 07 Jul 2021 1 +$5,000,000 4 Director 09 Jul 2021, 18:39
/report/000106299321006119-perceptive-advisors-llc-2021-06-29 VBI Vaccines Inc/BC 29 Jun 2021 2 -$2,455,777 4 10%+ Owner 30 Jun 2021, 16:40
MGTX MeiraGTx Holdings plc 10 Jun 2021 2 $0 4 Director, 10%+ Owner 14 Jun 2021, 17:23
/report/000106299321005610-perceptive-advisors-llc-2021-06-09 VBI Vaccines Inc/BC 09 Jun 2021 6 -$1,002 4 10%+ Owner 11 Jun 2021, 18:41
NAUT ARYA Sciences Acquisition Corp III 03 Jun 2021 1 +$3,317,002 4 Director 03 Jun 2021, 18:55
ATHA Athira Pharma, Inc. 28 May 2021 1 $0 4 Director 01 Jun 2021, 19:58
NAUT Nautilus Biotechnology, Inc. 24 May 2021 3 +$55,070,983 4 Former Director 11 Jun 2021, 17:45
NAUT ARYA Sciences Acquisition Corp III 20 May 2021 1 +$1,607,246 4 Director 24 May 2021, 18:49
NAUT ARYA Sciences Acquisition Corp III 20 May 2021 0 $0 3 Director 24 May 2021, 18:48
VYNE VYNE Therapeutics Inc. 06 May 2021 1 -$3,670,000 4 10%+ Owner 07 May 2021, 17:31